OBJECTIVES: Various non-sternotomy approaches have been used for left internal mammary artery (LIMA) grafting in left single-vessel revascularization. The aim of this study was to evaluate the impact of three different non-sternotomy techniques on long-term outcomes after left single-vessel revascularization.
INTRODUCTION
Coronary artery bypass grafting (CABG) has revolutionized the natural history and quality of life of patients with ischaemic heart disease by providing more symptomatic relief than any other surgical procedure in the history of medicine [1] . Up to date, CABG with cardiopulmonary bypass (CPB) is considered the gold standard for surgical coronary revascularization [2] . However, in the last two decades, there has been significant and successful progress in the development of alternative, less-invasive multivessel revascularization techniques in order to minimize the adverse effects associated with the use of CPB [3, 4] . Furthermore, given the survival advantage of left internal mammary artery (LIMA) to left anterior descending (LAD) artery grafting [5] , patients continue to be referred to cardiac surgeons for not only multivessel disease, but also isolated proximal left coronary disease [6] . Nevertheless, as advances in technology continue to evolve, minimally invasive options for CABG are increasingly being utilized for the routine avoidance of sternotomy while maintaining direct vision and manipulations [7, 8] . Whereas options for minimally invasive coronary surgery (MICS) now include standard minimally invasive direct coronary artery bypass (MIDCAB), endoscopically assisted coronary artery bypass (EACAB), robotically assisted direct coronary artery bypass (RADCAB) and robotically assisted totally endoscopic coronary artery bypass (TECAB) [9] , there are limited data comparing these non-sternotomy approaches for isolated proximal LAD artery disease [10] . In this respect, the purpose of this study was to evaluate the impact of three different approaches-MIDCAB, EACAB and RADCAB-on in-hospital and long-term outcomes after nonsternotomy left single-vessel revascularization.
MATERIALS AND METHODS
This study was categorized as a Service Evaluation by the Ethical Committee of Royal Brompton & Harefield NHS Foundation Trust and required no need for ethical approval. The study design was a retrospective review of prospectively collected data. The institutional European Association for Cardio-Thoracic Surgery (EACTS) Adult Cardiac Database was reviewed. A total number of 11 984 CABG were performed at Royal Brompton & Harefield NHS Foundation Trust between April 2003 and May 2013. Of these, 502 (4.19%) patients who underwent single-vessel CABG with LIMA to LAD artery grafting without median sternotomy were included in the study. Patients with multivessel disease or those undergoing a hybrid procedure or concomitant surgery at the time of CABG were excluded from this analysis. Patients were divided in three groups according to the technique used: MIDCAB group (n = 189, 37.6%), EACAB group (n = 76, 15.1%) and RADCAB group (n = 237, 47.2%). Indication for coronary surgery was established on the basis of applicable current international guidelines [11] . To control selection bias and other confounders which might have an impact on outcomes, we performed propensity scorebased matching based on preoperative variables that were significantly different or showed a trend. Seventy-six patients from each group were included in this analysis.
Antibiotic prophylaxis and surgical site preparation
The antibiotic regimen was the same for all groups and comprised Cefuroxime 1.5 g i.v. bolus at induction, 750 mg i.v. at the conclusion of surgery, followed by two further boluses of 750 mg 12 h apart, along with Teicoplanin 400 mg i.v. bolus at induction followed by 400 mg i.v. bolus after 12 h. The surgical site was prepared by scrubbing with iodinated povidone 10% w/w solution, followed by painting twice with Videne Alcoholic Tincture (Ecolab Ltd, Leeds, UK) prior to draping.
Bypass graft quality assessment
The quality control of the anastomosis was performed using intraoperative transit time flow measurement at the end of the operation as per hospital protocol. Once the anastomoses were completed, the graft flows were measured while the systolic blood pressure was maintained at >100 mmHg. The mean flows (ml/min), the pulsatility index (PI) and the shape of the waveform were assessed. The criteria for chest closure were a PI of <5 and absence of systolic spikes.
Surgical techniques
Minimally invasive direct coronary artery bypass grafting.
This procedure involves a 5-to 7-cm left anterolateral thoracotomy incision through the fourth intercostal space. A double-lumen endotracheal tube or bronchial blocker was used to decompress the left lung. Specialized retractors (Thoratrak, Medtronic, Inc., Minneapolis, MN, USA) elevated the anterior chest wall to facilitate harvest of the LIMA under direct vision. Following LIMA pedicle harvesting using diathermy and pericardiotomy, the LIMA to LAD anastomosis was performed (hand-sewn) off-pump on the beating heart with the aid of stabilizers (Octopus and Octopus Nuvo, Medtronic, Inc.) that provide a relatively motionless field.
Endoscopically assisted coronary artery bypass grafting.
Patients were placed in a supine position with the left side elevated from 15 to 30°. A short 5 mm/30°telescope (Karl Storz, Tuttlingen, Germany) and two instrument arm ports (Endopath® Xcel™ Universal Trocar Sleeve and Endopath® Xcel™ Bladeless Trocar, Ethicon Endo-Surgery, Norderstedt, Germany) were placed 3-5 cm medial to the anterior axillary line in the second, fourth and sixth intercostal spaces or the third, fifth and seventh intercostal spaces based on the body habitus. Carbon dioxide insufflation at 10-15 mmHg was initiated. The LIMA was harvested endoscopically, using a laparoscopic handset with suction function, a 36-cm laparoscopic straight spatula electrode and a hook (Valleylab™, Covidien, Mansfield, MA, USA), left and right endoscopic ligaclip applicators (Karl Storz) and an endoscopic instrument set containing a forceps, a curved scissors and a suture carrier (CalMedical, Lanark, UK). After heparinization, the LIMA was transected distally and the pericardium was opened. A long spinal needle was then passed through the anterior chest wall to localize the planned site of the 3-to 4-cm anterolateral thoracotomy incision, usually in the fourth or fifth intercostal space. As the left side of the chest was deflated, the heart returned to its normal position within the left hemithorax and the planned site of anastomosis on the LAD artery was visualized. A soft tissue retractor (CardioVations, Edwards Lifesciences, Irvine, CA, USA) was used to provide exposure through the interspace. The LIMA was retrieved into the operating field and prepared for the anastomosis. The LAD artery target was exposed and stabilized using a minimally invasive stabilizer (Octopus Nuvo, Medtronic, Inc.) and the anastomosis was performed manually using fine monofilament suture.
Robotically assisted direct coronary artery bypass grafting.
RADCAB was performed using a computer-enhanced surgical telemanipulation system that provides the surgeon with a 3D view of the surgical field and which is described elsewhere [12] . In brief, the robot itself consists of a two-part system called AESOP and ZEUS. AESOP is a speech-recognition-controlled robotic endoscope positioner that controls the camera that responds to the surgeon's verbal commands. AESOP approximates the form and function of a human arm and allows control of the camera in a way superior to conventional methods. The ZEUS system consists of two robotic instrument positioning arms attached to the operating table, a computer controller, an ergonomic surgeon's console that houses the master controls operated by the surgeon and a 3D module for viewing the image from the AESOP 3D camera. From the surgeon's console, which is situated away from the patient, the surgeon controls the camera and the instrument arms, which interpret and replicate the movements of the surgeon's hands through seven degrees of freedom mimicking the human wrist, but with greater accuracy due to motion scaling, tremor filtration and improved dexterity. The RADCAB involved harvesting the LIMA with robotic assistance through small ports, followed by pericardiotomy. The target site could then be localized under endoscopic guidance with a spinal needle, which allows for precise planning of the anterolateral thoracotomy incision. The coronary anastomosis is then performed through a small minithoracotomy under direct visualization off-pump, on beating heart, with standard coronary instruments and stabilizers as previously described.
Statistical analysis
Statistical analysis was performed using IBM SPSS Statistics version 21 software (IBM Corp.). All data are presented as continuous or categorical variables. Continuous variables were evaluated for normality using one sample Kolmogorov-Smirnov test and are expressed as mean ± standard deviation in cases of normally distributed variables or median (interquartile range) in cases of non-normally distributed variables. Inter-group comparisons were performed using one-way ANOVA or Kruskal-Wallis test for normal and non-normal continuous variables, respectively. Categorical data are expressed as total numbers and percentages. Pearson's χ 2 or Fisher's exact tests were used for categorical data dependent on the minimum expected count in each cross tab.
The propensity score was developed using the logistic regression model. P < 0.05 was considered statistically significant.
RESULTS

Unadjusted analysis
Patient's demographics and preoperative data are summarized in Table 1 . There were no statistically significant differences among the three groups regarding age, gender, body mass index (BMI) and EuroSCORE. At the time of revascularization, patients had comparable left ventricular function and preoperative haemodynamic status. Also, the groups were comparable regarding patients' comorbidities ( Table 2) .
Patients from the EACAB group underwent significantly more urgent and emergent procedures compared with the RADCAB and MIDCAB groups (P = 0.015). The duration of surgery was significantly longer in the RADCAB group: 230 (205;260) min in the RADCAB vs 120 (92;149) min in the EACAB and 100 (80;130) min in the MIDCAB groups (P < 0.001). There was no significant difference in terms of intraoperative conversion to sternotomy (Table 3) : 2.5% in the RADCAB vs 1.3% in the EACAB and 1.1% in the MIDCAB groups (P = 0.494).
Patients from the MIDCAB group had a significantly higher number of superficial and deep wound infections (P = 0.012) and a significantly higher number of patients requiring blood transfusions (P = 0.009), whereas there were no differences regarding reopening for bleeding (P = 0.975, Table 3 ). Patients who developed superficial infections had a non-significantly longer total in-hospital stay compared with those who were free of wound infections (9.7 ± 6.6 vs 6.9 ± 8.0 days, P = 0.285), and patients with deep wound infections had a significantly longer total in-hospital stay (42.5 ± 17.7 days, P < 0.001). One patient who developed a deep wound infection requiring surgical revision died in hospital following sepsis. All other patients with superficial and deep wound infections did not require surgical treatment and did not develop further related complications.
Postoperatively, two in-hospital deaths and one need for reoperation were observed in the MIDCAB group, one in-hospital death in the RADCAB group and no in-hospital mortality or reoperations in the EACAB group; however, these differences were not statistically significant. The cumulative survival rates for MIDCAB, EACAB and RADCAB were 97.3, 98.6 and 97.8% at 1 year, 95, 97 and 96.7% at 3 years and 72.2, 90.4 and 84.8% at 10 years, respectively (Fig. 1 ). There were no statistically significant differences in terms of cumulative major adverse cardiovascular events (MACEs) over the 10-year follow-up with 37 events (including 4 deaths, 4 strokes and 3 reoperations) in the MIDCAB group, 5 (no deaths, 1 stroke, no reoperations) in the EACAB group and 25 (2 deaths, 3 strokes, 1 reoperation) in the RADCAB group (Table 4) . Rates of freedom from MACEs over 10 years was 88.5% in the MIDCAB group, 95.4% in the EACAB group vs 86.3% in the RADCAB groups; however, these differences did also not reach statistical significance (Fig. 2) . Also, the cohorts were comparable regarding further perioperative parameters, such as intra-and postoperative haemodynamics, incidences of neurological, renal and gastrointestinal complications, multiorgan failure and intensive care unit (ICU)-and in-hospital length of stay (Table 4) . Postoperative follow-up angiographies were not performed routinely. Some angiographies were done when individual patients had strong indications for this investigation. However, as the number of patients who developed symptoms with indication for an angiography was relatively small, we did not have sufficient data for analysis.
Results after propensity score matching
After propensity score matching, three groups became comparable in terms of all preoperative variables. Particularly, preoperative variables that were statistically different or showed trends among the groups in the overall analysis became comparable after propensity score adjustment. The duration of surgery was still significantly longer in the RADCAB group: 234 (210;260) min in the RADCAB vs 120 (91;75) min in the EACAB and 90 (80;120) min in the MIDCAB groups (P < 0.001). There was no significant difference in terms of intraoperative conversion to sternotomy: 1.3% in the RADCAB vs 1.3% in the EACAB and 0% in the MIDCAB groups (P = 0.604).
Patients from the MIDCAB group had still higher number of superficial and deep wound infections compared with EACAB and RADCAB groups; however, it was not statistically significant: 6.6 vs 2.6 vs 1.3% for superficial and 2.6 vs 0 vs 0% for deep infections (P = 0.110). The differences in the number of patients requiring blood transfusions became also not significant (P = 0.121), and there were no differences regarding reopening for bleeding (P = 0.363). The cumulative survival rates for MIDCAB, EACAB and RADCAB remained statistically not different and were 98.7, 98.6 and 97.3% at 1 year, 98.7, 97 and 95.7% at 3 years, and 79.6, 90.4 and 88.1% at 10 years, respectively (Fig. 3 ). There were no statistically significant differences in terms of myocardial infarction (P = 0.239), cerebrovascular events (P = 0.404), cardiac death (P = 0.239), need for reintervention (P = 0.152) and reoperation (P = 0.363) over the 10-year follow-up. However, the EACAB group was associated with significantly lower incidence of angina compared with the MIDCAB and EACAB groups (P = 0.034, Table 4 ). The rate of freedom from MACE over 10 years was 74.5% in the MIDCAB group, 95.4% in the EACAB group vs 64.9% in the RADCAB group (P = 0.030, Fig. 4) . A subgroup analysis comparing freedom from MACEs in all possible group pairs revealed a significantly longer freedom from MACEs in the EACAB group compared with both the MIDCAB (P = 0.007) and RADCAB (P = 0.035) groups, whereas there were no statistically significant differences between the MIDCAB and RADCAB groups (P = 0.536).
Revascularization through median sternotomy
Three patients underwent single-vessel revascularization via median sternotomy during the study period-all were operated on off-pump. Median sternotomy is not the standard approach for single-vessel revascularization in our institution where minimally invasive strategies are successfully practised. The indication for median sternotomy was a potential two-vessel revascularization which, however, was not performed due to the small calibre of the second target vessel. All 3 patients had an uneventful recovery, were discharged home and are doing well. Except for a superficial sternal wound infection without the need for surgical treatment, there were no adverse events in this small patient cohort during 1709 ± 520 days of mean follow-up.
DISCUSSION
The purpose of this study was to determine whether different non-sternotomy approaches to minimally invasive LIMA to LAD CABG impact in-hospital or long-term outcomes. To our knowledge, this is the first study comparing outcomes and adverse events after single-vessel revascularization using MIDCAB, EACAB and RADCAB techniques. Whereas MICS is considered to be more technically demanding, requiring careful planning and preparation to achieve optimal exposure, and affording limited aortoatrial access for expedient CPB support, several studies have documented the safety, feasibility and advantages of MICS when compared with CABG via a median sternotomy [9, 13] . Over the past decade, options for MICS have evolved to include MIDCAB, EACAB and robotic approaches-either robotically assisted or totally robotic which includes the use of a robotic technique for coronary anastomoses as well. In this paper, we focused on the robotically assisted approach in order to have comparable groups in terms of performing distal anastomoses and only assessing three different non-sternotomy approaches. In our study, all distal anastomoses were performed through anterolateral ministernotomy, hand-sewn under direct vision, and outcomes in totally robotic revascularization would have been biased by the different performance of distal anastomoses.
MIDCAB continues to be a popular and well-documented approach for non-sternotomy CABG. Holzhey et al. [14] recently reported on a series of 1768 MIDCAB procedures with up to 10 years of follow-up, documenting excellent clinical outcomes with 5-and 10-year survival rates of 88.3 and 76.6%, respectively, and rates of freedom from MACEs of 85.3 and 70.9% at 5 and 10 years, respectively. In comparison, our study had 5-and 10-year survival rates of 90.6 and 72.2%, respectively. Several other studies have corroborated these results [15] [16] [17] [18] . EACAB also has its proponents, with the advantage of being less traumatic than MIDCAB and less resource-intensive than RADCAB. Vassiliades et al. [19] studied 607 EACAB patients undergoing endoscopic LIMA to LAD grafting and reported a 30-day mortality rate of 1%, with a 5-year event-free survival rate of 92 ± 2.4%, which also corroborates results of our EACAB group. RADCAB remains the most resource-intensive approach; however, several specialized centres have reported excellent clinical outcomes attesting to its safety and efficacy [20] [21] [22] . Nesher et al. reported on a cohort of 146 patients undergoing RADCAB, with no in-hospital deaths or postoperative myocardial infarctions [20] . More recently, Halkos et al. reported short-term results in a series of 307 RADCAB procedures (including 159 hybrid procedures) with 1.3% 30-day mortality, 5.2% conversion to sternotomy, 1.6% postoperative myocardial infarction and 2.3% incidence of re-exploration for bleeding [21] . The results for our RADCAB group compare favourably to these, with 0.4% in-hospital mortality, 2.5% conversion to sternotomy, 0.8% postoperative myocardial infarction and 1.7% incidence of re-exploration for bleeding.
Our study confirms that MICS, regardless of the individual approach used, is safe with a very low early mortality and freedom from reintervention, and effective with excellent long-term survival and freedom from MACEs. Given that patient demographics and preoperative parameters were comparable across all groups in this study, comparative analysis of outcomes from the individual approaches brought forth some pertinent considerations. Although a significantly higher number of patients from the EACAB group underwent urgent and emergent procedures when compared with the MIDCAB and RADCAB groups, this did not translate into inferior outcomes in terms of mortality and reintervention, and the three groups were comparable regarding conversion to sternotomy, ICU readmission and other postoperative complications. Patients from the EACAB group had the best survival and the longest freedom from MACEs among the three groups compared (Figs 1-4 ), although these differences were not statistically significant, and this group represented only 15.1% of the entire cohort. However, after propensity score matching, the freedom from MACEs was even significantly longer in the EACAB group compared with both MIDCAB and RADCAB groups. The median operative duration for EACAB was 20 min (30 min after propensity score matching) longer than that for MIDCAB and almost half as that for RADCAB. Whereas the additional operative duration for RADCAB was highly significant (P < 0.001), the benefit of lower operative duration for the MIDCAB group came at the expense of postoperative superficial and deep wound infections. However, most infections were not associated with increased morbidity and mortality, and only 1 case with deep wound infection led to sepsis and in-hospital mortality. Even after propensity score matching, the highest incidence of both superficial and deep infections remained in the MIDCAB group. Thus, EACAB occupied the middle position between the opposing extremes of MIDCAB and RADCAB in the trade-off between operative duration and postoperative wound infections. Furthermore, EACAB was the most favourable group in terms of freedom from MACEs, mostly caused by a significantly lower incidence rate of postoperative angina at only 2.6% of patients who developed angina over the follow-up, compared with 11.8% in the RADCAB and 14.5% in the MIDCAB groups (P = 0.034). The lower incidence of angina following EACAB may be attributable to: (i) better quality of LIMA harvest in EACAB resulting in lesser injury, (ii) surgeon factors-individual technique, (iii) fortuitous lower progression of the disease in the EACAB group and, possibly, (iv) a combination of the above. Whereas all anastomoses were subject to a uniform quality-control policy, vide supra, definitive conclusions are not possible without postoperative angiography data, which were unavailable in this retrospective study, and any inferences regarding the underlying mechanisms for lower incidence of angina following EACAB remain speculative at best. Nevertheless, higher incidence of angina in the MIDCAB and RADCAB groups did not translate into a higher incidence of myocardial infarction, and the shorter freedom from MACEs did not affect overall survival in both groups.
Limitations
Given the retrospective nature of this study, a relatively small patient cohort and a lack of routine postoperative angiographic surveillance, a definitive elucidation of the differences in outcomes with individual approaches is not possible based on the results of this analysis. As this investigation was a non-blinded study of single-vessel surgical coronary revascularization carried out by different surgeons, we cannot exclude all possible bias and confounding in terms of patient selection and surgical management that may have affected patient outcomes. For that reason, the conclusions based on the unadjusted analysis might be less robust given the fact that treatment comparisons were made in an uncontrolled setting. Furthermore, no comparisons to isolated on-pump left single-vessel revascularization through median sternotomy were made.
CONCLUSION
In summary, MIDCAB, EACAB and RADCAB approaches in single-vessel coronary revascularization are clinically safe and effective, with comparable in-hospital mortality and long-term survival. However, the endoscopic approach was found to be free from the disadvantages of longer operating duration observed in the RADCAB or higher incidence of angina and shorter freedom from MACEs in both the MIDCAB and RADCAB groups. Further studies, possibly prospective randomized trials, are warranted to confirm these preliminary results regarding effectiveness and safety of different non-sternotomy approaches to left single-vessel revascularization.
